Related Experiment Video
Updated: Jul 5, 2025
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
793
Digital Technologies in Heart Failure Management
Evrim Şimşek1, Yetkin Korkmaz2, Serdar Bozyel3
1Department of Cardiology, Ege University Faculty of Medicine, Izmir, Türkiye.
Summary
Digital technologies and wearable devices can help monitor heart failure (HF) patients remotely. This approach aims to prevent hospitalizations and mortality by detecting decompensation early, improving patient outcomes.
Area of Science:
- Cardiology
- Digital Health
- Biomedical Engineering
Background:
- Heart Failure (HF) poses a significant global public health challenge.
- HF decompensation leads to increased hospitalizations and mortality.
- Digital technologies, particularly wearables, are increasingly adopted in healthcare.
Purpose of the Study:
- To review the role of digital technologies in monitoring Heart Failure patients.
- To discuss the evidence supporting remote monitoring and artificial intelligence in HF management.
- To identify barriers to the clinical implementation of these technologies.
Main Methods:
- Literature review of digital biomarkers, remote monitoring systems, and AI applications in HF.
- Analysis of evidence supporting the use of digital technologies for early detection of HF decompensation.
- Discussion of limitations and challenges in integrating digital health tools into clinical practice.
Main Results:
- Digital technologies enable continuous patient monitoring, potentially detecting early signs of HF decompensation.
- Remote monitoring systems and AI show promise in improving patient outcomes and reducing hospitalizations.
- Evidence supports the use of digital biomarkers for proactive HF management.
Conclusions:
- Digital technologies offer a promising avenue for enhanced Heart Failure management.
- Early detection of decompensation through remote monitoring can reduce mortality and hospitalizations.
- Addressing implementation barriers is crucial for widespread clinical adoption.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
01:22Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
01:30Pulse rhythm
803
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
803
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K